Zobrazeno 1 - 10 of 340 pro vyhledávání: '"Heald N"'
1
Akademický článek
Exploring the potential of small molecules of dual c-Met and VEGFR inhibitors for advances and future drug discovery in cancer therapy.
Autor: Dhawale, Sachin A.1 (AUTHOR) sdhawale021@gmail.com, Deokar, Arundhati V.1 (AUTHOR), Firdous, Momin Aaliya1 (AUTHOR), Pandit, Madhuri2 (AUTHOR), Chaudhari, Minal Y.1 (AUTHOR), Salve, Sameer B.1 (AUTHOR), Khandgaonkar, Madhuri1 (AUTHOR), Parwe, Mahesh1 (AUTHOR), Khalse, Rupesh1 (AUTHOR), Dake, Shruti G.1 (AUTHOR), Chatse, Siddharth H.1 (AUTHOR), Tapadiya, Ganesh G.1 (AUTHOR)
Publikováno v: Future Journal of Pharmaceutical Sciences. 9/18/2024, Vol. 10 Issue 1, p1-16. 16p.
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Quantitative assessment of antibody internalization with novel monoclonal antibodies against Alexa fluorophores.
Autor: Liao-Chan S; Department of Discovery Research, Igenica Biotherapeutics, Burlingame, California, United States of America., Daine-Matsuoka B; Department of Discovery Research, Igenica Biotherapeutics, Burlingame, California, United States of America., Heald N; Department of Discovery Research, Igenica Biotherapeutics, Burlingame, California, United States of America., Wong T; Department of Discovery Research, Igenica Biotherapeutics, Burlingame, California, United States of America., Lin T; Department of Discovery Research, Igenica Biotherapeutics, Burlingame, California, United States of America., Cai AG; Department of Discovery Research, Igenica Biotherapeutics, Burlingame, California, United States of America., Lai M; Department of Discovery Research, Igenica Biotherapeutics, Burlingame, California, United States of America., D'Alessio JA; Department of Discovery Research, Igenica Biotherapeutics, Burlingame, California, United States of America., Theunissen JW; Department of Discovery Research, Igenica Biotherapeutics, Burlingame, California, United States of America.
Publikováno v: PloS one [PLoS One] 2015 Apr 20; Vol. 10 (4), pp. e0124708. Date of Electronic Publication: 2015 Apr 20 (Print Publication: 2015).
Zobrazit plný text záznamu
4
Akademický článek
Oxidative Stress and the Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Pathway in Multiple Sclerosis: Focus on Certain Exogenous and Endogenous Nrf2 Activators and Therapeutic Plasma Exchange Modulation.
Autor: Tonev, Dimitar1 (AUTHOR) dgtsofia@abv.bg, Momchilova, Albena2 (AUTHOR) albena_momchilova@abv.bg
Publikováno v: International Journal of Molecular Sciences. Dec2023, Vol. 24 Issue 24, p17223. 23p.
Zobrazit plný text záznamu
5
Akademický článek
晚期 RET 融合阳性非小细胞肺癌诊疗 中国专家共识（2023 版）.
Autor: 韩宝惠1 hanbaohui@csco.org.cn
Publikováno v: Chinese Journal of Oncology. Dec2023, Vol. 45 Issue 12, p991-1002. 12p.
Zobrazit plný text záznamu
6
Akademický článek
Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET.
Autor: Sahakian, Nicolas1 (AUTHOR) nicolas.sahakian@ap-hm.fr, Castinetti, Frédéric1 (AUTHOR) frederic.castinetti@ap-hm.fr, Romanet, Pauline2 (AUTHOR) pauline.romanet@univ-amu.fr
Publikováno v: Cancers. Oct2023, Vol. 15 Issue 19, p4865. 27p.
Zobrazit plný text záznamu
7
Akademický článek
RET -Altered Cancers—A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity.
Autor: Desilets, Antoine1 (AUTHOR) desilea@mskcc.org, Repetto, Matteo1,2 (AUTHOR) repettom@mskcc.org, Yang, Soo-Ryum1 (AUTHOR) yangs2@mskcc.org, Sherman, Eric J.1,3 (AUTHOR) shermane@mskcc.org, Drilon, Alexander1,3 (AUTHOR) drilona@mskcc.org
Publikováno v: Cancers. Aug2023, Vol. 15 Issue 16, p4146. 24p.
Zobrazit plný text záznamu
8
Akademický článek
In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer.
Autor: Bentzien F; Exelixis, Inc. , South San Francisco, California., Zuzow M, Heald N, Gibson A, Shi Y, Goon L, Yu P, Engst S, Zhang W, Huang D, Zhao L, Vysotskaia V, Chu F, Bautista R, Cancilla B, Lamb P, Joly AH, Yakes FM
Publikováno v: Thyroid : official journal of the American Thyroid Association [Thyroid] 2013 Dec; Vol. 23 (12), pp. 1569-77. Date of Electronic Publication: 2013 Sep 17.
Zobrazit plný text záznamu
9
Akademický článek
Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitors.
Autor: Leahy JW; Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States., Buhr CA, Johnson HW, Kim BG, Baik T, Cannoy J, Forsyth TP, Jeong JW, Lee MS, Ma S, Noson K, Wang L, Williams M, Nuss JM, Brooks E, Foster P, Goon L, Heald N, Holst C, Jaeger C, Lam S, Lougheed J, Nguyen L, Plonowski A, Song J, Stout T, Wu X, Yakes MF, Yu P, Zhang W, Lamb P, Raeber O
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2012 Jun 14; Vol. 55 (11), pp. 5467-82. Date of Electronic Publication: 2012 May 17.
Zobrazit plný text záznamu
10
Akademický článek
Discovery of a novel class of potent and orally bioavailable sphingosine 1-phosphate receptor 1 antagonists.
Autor: Ibrahim MA; Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States., Johnson HW, Jeong JW, Lewis GL, Shi X, Noguchi RT, Williams M, Leahy JW, Nuss JM, Woolfrey J, Banica M, Bentzien F, Chou YC, Gibson A, Heald N, Lamb P, Mattheakis L, Matthews D, Shipway A, Wu X, Zhang W, Zhou S, Shankar G
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2012 Feb 09; Vol. 55 (3), pp. 1368-81. Date of Electronic Publication: 2012 Jan 24.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje